Trial Profile
A Phase II trial of XRx 221 for treatment of Diabetic Nephropathy
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2018
Price :
$35
*
At a glance
- Drugs XRx 221 (Primary)
- Indications Diabetic nephropathies
- Focus Proof of concept; Therapeutic Use
- 25 Jul 2018 New trial record